Author details

Full Name

Chung-Hsin Chen

Affiliation

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37340337	Survival outcomes and prognostic factors for first-line abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer.		2023
36369801	Risk of cognitive impairment in men with advanced prostate cancer treated with NHAs: A systematic review and network meta-analysis.	Clinical and Translational Science	2023
35867141	Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.	World Journal of Urology	2023
37853534	Active Surveillance for Taiwanese Men with Localized Prostate Cancer: Intermediate-Term Outcomes and Predictive Factors.		2023
37821919	Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study.		2023
37568689	Primary Total Prostate Cryoablation for Localized High-Risk Prostate Cancer: 10-Year Outcomes and Nomograms.		2023
36969664	Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma.		2023
34716480	Comparison of oncological outcomes for hand-assisted and pure laparoscopic radical nephroureterectomy: results from the Taiwan Upper Tract Urothelial Cancer Collaboration Group.	Surgical Endoscopy and Other Interventional Techniques	2022
35912236	Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the Prostate.	Frontiers in Oncology	2022
35968338	LMNB1, a potential marker for early prostate cancer progression.	American Journal of Cancer Research (discontinued)	2022
35691449	Tumor-Derived C-C Motif Ligand 2 Induces the Recruitment and Polarization of Tumor-Associated Macrophages and Increases the Metastatic Potential of Bladder Cancer Cells in the Postirradiated Microenvironment.	International Journal of Radiation Oncology Biology Physics	2022
35864293	Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer.	Scientific Reports	2022
33715926	Clinical characteristics and survival outcomes in patients with a high PSA and non-metastatic prostate cancer.	Journal of the Formosan Medical Association	2022
34439119	High Tumor Burden Predicts Poor Response to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients.	Cancers	2021
34071587	Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy.	Cancers	2021
32591157	Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer.	Journal of the Formosan Medical Association	2021
33277322	Additive Effects of Arsenic and Aristolochic Acid in Chemical Carcinogenesis of Upper Urinary Tract Urothelium.	Cancer Epidemiology Biomarkers and Prevention	2021
33417948	Tumor location on MRI determines outcomes of patients with prostate cancer after total prostate cryoablation.	Cryobiology	2021
33051982	Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study.	Asia-Pacific Journal of Clinical Oncology	2021
34634362	Loss of proximal tubular transcription factor KrÃ¼ppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidation.	Kidney Int	2021
34561545	Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy.	Scientific Reports	2021
34439261	Extranodal Extension Predicts Poor Survival Outcomes among Patients with Bladder Cancer.	Cancers	2021
32051516	Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.	Scientific Reports	2020
32199754	Acrolein contributes to urothelial carcinomas in patients with chronic kidney disease.	Urologic Oncology: Seminars and Original Investigations	2020
31964956	Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy.	Scientific Reports	2020
31512280	Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web-based survey.	Int J Urol	2019
30539227	Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral center.	World Journal of Urology	2019
31263127	The impact of primary location and age at orchiopexy on testicular atrophy for congenital undescended testis.	Scientific Reports	2019
29557778	Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.	Elife	2018
30418154	Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.	Elife	2018
29626465	Adjuvant androgen-deprivation therapy following prostate total cryoablation in high-risk localized prostate cancer patients - Open-labeled randomized clinical trial.	Cryobiology	2018
27506334	Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation.		2017
28668478	Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population.	Urologic Oncology: Seminars and Original Investigations	2017
29118397	The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.	Scientific Reports	2017
27555084	Aristolochic Acid in the Etiology of Renal Cell Carcinoma.	Cancer Epidemiology Biomarkers and Prevention	2016
27286260	Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma.	Oncotarget	2016
27256663	Perioperative changes in TGF-Î²1 levels predict the oncological outcome of cryoablation-receiving patients with localized prostate cancer.	Cryobiology	2016
26351152	The effect of tumor location on oncologic outcomes in patients with upper urinary tract urothelial carcinoma stratified by pathologic stage.	Urologic Oncology: Seminars and Original Investigations	2016
27689065	Asia prostate cancer study (A-CaP Study) launch symposium.	Prostate Int	2016
26545980	The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer.	World Journal of Surgical Oncology	2015
25552206	Prognostic value of saturated prostate cryoablation for localized prostate cancer.	World Journal of Urology	2015
25874217	Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.	BioMed Research International	2015
25363092	Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma.	Diabetes/Metabolism Research and Reviews	2015
24936140	Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.	Int J Med Sci	2014
24033515	Emphysematous pyelonephritis: clinical characteristics and prognostic factors.	International Journal of Urology	2014
23987245	Laparoscopic radical prostatectomy monotherapy, a more aggressive yet less invasive option, is oncologically effective in selected men with high-risk prostate cancer having only one D'Amico risk factor: experience from an Asian tertiary referral center.	Journal of Endourology	2014
24662028	Proactive rectal warming during total-gland prostate cryoablation.	Cryobiology	2014
23292929	Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.	International Journal of Cancer	2013
22987331	Using age-referenced prostate-specific antigen percentile to predict survival outcomes in screened Taiwanese men.	International Journal of Cancer	2013
23926200	Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.	Sci Transl Med	2013